Pilar Jimenez-Quevedo

Showing 1-16 of 16 articles

Interventions for valvular disease

Percutaneous Edge-To-Edge Mitral Repair in the Presence of Mitral Annulus Calcification

Fernandez Peregrina E, Pascual I, Freixa X, Tirado-Conte G, Estevez-Loureiro R, Carrasco-Chinchilla F, Benito-González T, Asmarats L, Sanchis L, Jimenez-Quevedo P, Avanzas P, Caneiro-Queija B, Molina-Ramos AI, Fernández-Vázquez F, Chi Hi L, Flores-Ulmanzor E, Sans-Roselló J, Nombela-Franco L, Arzamendi D

August 31, 2021 | 10.4244/EIJ-D-21-00205

STEMI

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabaté M

March 20, 2018 | 10.4244/EIJ-D-17-00608

Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischaemic heart disease

Echavarría-Pinto M, van der Hoef T, Nijjer S, Gonzalo N, Nombela-Franco L, Ibáñez B, Sen S, Petraco R, Jimenez-Quevedo P, Núñez-Gil I, Cerrato E, Salinas P, Quirós A, Garcia-Garcia H, Fernandez Ortiz A, Macaya C, Davies J, Piek J, Escaned J

October 20, 2017 | 10.4244/EIJ-D-16-00525

Coronary interventions

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabaté M

August 4, 2017 | 10.4244/EIJ-D-16-00512

Coronary interventions

Spain: coronary and structural heart interventions from 2010 to 2015

García del Blanco B, Jimenez-Quevedo P, Diaz J, Hernandez F, Rumoroso J-R, Sabaté M, de la Torre Hernandez J, Serrador A, Pérez de Prado A, Goicolea J, Trillo R, Pan M

May 15, 2017 | 10.4244/EIJ-D-16-00834

Interventions for valvular disease

Outcomes and predictors of success and complications for paravalvular leak closure: an analysis of the SpanisH real-wOrld paravalvular LEaks closure (HOLE) registry

Garcia E, Arzamendi D, Jimenez-Quevedo P, Sarnago F, Martí G, Sanchez Recalde A, Lasa-Larraya G, Sancho M, Iñiguez A, Goicolea J, Roman K, Alonso-Briales J, Molina E, Calabuig J, Freixa X, Berenguer A, Valdés Chávarri M, Vázquez N, Diaz J, Cruz-Gonzalez I

March 20, 2017 | 10.4244/EIJ-D-16-00581

Coronary interventions

Fractional flow reserve and minimum Pd/Pa ratio during intravenous adenosine infusion: very similar but not always the same

Echavarría-Pinto M, Petraco R, van der Hoef T, Gonzalo N, Nijjer S, Tarkin J, Ibáñez B, Sen S, Jimenez-Quevedo P, Núñez-Gil I, Nombela-Franco L, Alfonso F, Fernandez Ortiz A, Macaya C, Piek J, Davies J, Escaned J

January 20, 2016 | 10.4244/EIJY14M10_09

Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

Alfonso F, Pérez-Vizcayno M, Cardenas A, García del Blanco B, García Touchard A, Lopez-Minguez J, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernandez Ortiz A, Escaned J, Jimenez-Quevedo P, Gonzalo N, Fernandez C, Macaya C

July 20, 2015 | 10.4244/EIJY14M09_07

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

Jimenez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabaté M

July 26, 2013 | 10.4244/EIJV9I3A54

Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction

Escaned J, Echavarría-Pinto M, Gorgadze T, Gonzalo N, Armengol F, Hernandez R, Jimenez-Quevedo P, Núñez-Gil I, Pérez-Vizcayno M, Alfonso F, Banuelos C, Ibáñez B, Garcia E, Fernandez Ortiz A, Macaya C

February 22, 2013 | 10.4244/EIJV8I10A178

The use of drug-eluting stents in venous coronary artery bypass grafts

Hernández-Antolín R, Alfonso F, Jimenez-Quevedo P

May 19, 2009

Treatment of patients with in-stent restenosis

Alfonso F, Pérez-Vizcayno M, Cruz A, García J, Jimenez-Quevedo P, Escaned J, Hernandez R

May 19, 2009

Digital enhancement of stent images in primary and secondary percutaneous coronary revascularisation

Córdova J, Aleong G, Colmenarez H, Cruz A, Canales E, Jimenez-Quevedo P, Hernández R, Alfonso F, Macaya C, Banuelos C, den Hartog W, Escaned J

May 19, 2009

What to do when everything has failed: alternative treatment strategies for failure revascularisations

Jimenez-Quevedo P, Ferrer G, Emerson Perín E

May 19, 2009

Dual quantitative coronary angiography: a novel approach to quantify intracoronary thrombotic burden

Aleong G, Vaqueriza D, del Valle R, Garcia H, Hernandez R, Alfonso F, Jimenez-Quevedo P, Banuelos C, Macaya C, Escaned J

January 20, 2009

Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome

Gomez-Moreno S, Sabaté M, Jimenez-Quevedo P, Vazquez P, Alfonso F, Angiolillo D, Hernández-Antolín R, Moreno R, Banuelos C, Escaned J, Macaya C

August 20, 2006

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.